{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T05:46:10Z","timestamp":1781761570934,"version":"3.54.5"},"reference-count":49,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2018,3,3]],"date-time":"2018-03-03T00:00:00Z","timestamp":1520035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>We previously designed and synthesized dehydroxyepoxyquinomicin (DHMEQ) as an inhibitor of NF-\u03baB based on the structure of microbial secondary metabolite epoxyquinomicin C. DHMEQ showed anti-inflammatory and anticancer activity in various in vivo disease models without toxicity. On the other hand, the process of cancer metastasis consists of cell detachment from the primary tumor, invasion, transportation by blood or lymphatic vessels, invasion, attachment, and formation of secondary tumor. Cell detachment from the primary tumor and subsequent invasion are considered to be early phases of metastasis, while tumor cell attachment to the tissue and secondary tumor formation the late phases. The assay system for the latter phase was set up with intra-portal-vein injection of pancreatic cancer cells. Intraperitoneal administration of DHMEQ was found to inhibit liver metastasis possibly by decreasing the expression of MMP-9 and IL-8. Also, when the pancreatic cancer cells treated with DHMEQ were inoculated into the peritoneal cavity of mice, the metastatic foci formation was inhibited. These results indicate that DHMEQ is likely to inhibit the late phase of metastasis. Meanwhile, we have recently employed three-dimensional (3D) culture of breast cancer cells for the model of early phase metastasis, since the 3D invasion just includes cell detachment and invasion into the matrix. DHMEQ inhibited the 3D invasion of breast cancer cells at 3D-nontoxic concentrations. In this way, DHMEQ was shown to inhibit the late and early phases of metastasis. Thus, DHMEQ is likely to be useful for the suppression of cancer metastasis.<\/jats:p>","DOI":"10.3390\/ijms19030729","type":"journal-article","created":{"date-parts":[[2018,3,6]],"date-time":"2018-03-06T07:37:25Z","timestamp":1520321845000},"page":"729","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Inhibition of Late and Early Phases of Cancer Metastasis by the NF-\u03baB Inhibitor DHMEQ Derived from Microbial Bioactive Metabolite Epoxyquinomicin: A Review"],"prefix":"10.3390","volume":"19","author":[{"given":"Yinzhi","family":"Lin","sequence":"first","affiliation":[{"name":"Department of Molecular Target Medicine, Aichi Medical University School of Medicine, 1-1 Yazako-Karimata, Nagakute 480-1195, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamami","family":"Ukaji","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Aichi Medical University School of Medicine, 1-1 Yazako-Karimata, Nagakute 480-1195, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Koide","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Aichi Medical University School of Medicine, 1-1 Yazako-Karimata, Nagakute 480-1195, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Umezawa","sequence":"additional","affiliation":[{"name":"Department of Molecular Target Medicine, Aichi Medical University School of Medicine, 1-1 Yazako-Karimata, Nagakute 480-1195, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,3,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1021\/np50066a009","article-title":"Isolation of a novel tyrosine kinase inhibitor, lavendustin A, from Streptomyces griseolavendus","volume":"52","author":"Onoda","year":"1989","journal-title":"J. Nat. Prod."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.7164\/antibiotics.46.1342","article-title":"Dephostasin, a novel protein tyrosine phosphatase inhibitor produced by Streptomyces. I. Taxonomy, isolation, and characterization","volume":"46","author":"Imoto","year":"1993","journal-title":"J. Antibiot."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1021\/np960346g","article-title":"Cyclopentabenzofuran lignan protein synthesis inhibitors from Aglaia odorata","volume":"59","author":"Ohse","year":"1996","journal-title":"J. Nat. Prod."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/S0040-4039(97)00016-6","article-title":"Akaterpin, a novel bioactive triterpene from the marine sponge Callyspongia sp.","volume":"38","author":"Fukami","year":"1997","journal-title":"Terrahedron Lett."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.chembiol.2004.05.016","article-title":"Isolation of heptadepsin, a novel bacterial cyclic depsipeptide that inhibits lipopolysaccharide activity","volume":"11","author":"Ohno","year":"2004","journal-title":"Chem. Biol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/ja.2012.112","article-title":"Migracins, A and B, new inhibitors of cancer cell migration, produced by Streptomyces sp.","volume":"66","author":"Arai","year":"2013","journal-title":"J. Antibiot."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Umezawa, K., Kojima, I., Simizu, S., Lin, Y.Z., Fukatsu, H., Koide, N., Nakade, Y., and Yoneda, M. (2017). Therapeutic a activity of plant-derived alkaloid conophylline on metabolic syndrome and neurodegenerative disease models. Hum. Cell.","DOI":"10.1007\/s13577-017-0196-4"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0960-894X(00)00114-1","article-title":"Synthesis of NF-\u03baB activation inhibitors derived from epoxyquinomicin C","volume":"10","author":"Matsumoto","year":"2000","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1006\/bbrc.1996.1335","article-title":"Inhibition of NF-\u03baB activation by panepoxydone","volume":"226","author":"Erkel","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"455","DOI":"10.7164\/antibiotics.51.455","article-title":"Cycloepoxydon: 1-hydroxy-2-hydroxymethyl-3-pent-1-enylbenzene1-hydroxy-2-hydroxymethyl-3-pent-1,3-dienylbenzene, new inhibitors of eukaryotic signal transduction","volume":"51","author":"Gehrt","year":"1998","journal-title":"J. Antibiot."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"7061","DOI":"10.1016\/j.tet.2004.01.103","article-title":"Preparation and biological activities of optically active dehydroxymethylepoxyquinomicin, a novel NF-\u03baB inhibitor","volume":"60","author":"Suzuki","year":"2004","journal-title":"Tetrahedron"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"7083","DOI":"10.1016\/j.tet.2010.07.013","article-title":"Chemoenzymatic synthesis of (2S,3S,4S)-form, the physiologically active stereoisomer of dehydroxymethylepoxyquinomicin (DHMEQ), a potent inhibitor on NF-\u03baB","volume":"66","author":"Hamada","year":"2010","journal-title":"Tetrahedron"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"27625","DOI":"10.1074\/jbc.M112063200","article-title":"Inhibition of TNF-\u03b1-induced nuclear translocation and activation of NF-\u03baB by dehydroxymethyl-epoxyquinomicin","volume":"277","author":"Ariga","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"5780","DOI":"10.1021\/jm8006245","article-title":"Inactivation of nuclear factor kappa B components by covalent binding of (\u2212)-dehydroxymethylepoxyquinomicin to specific cysteine residues","volume":"51","author":"Yamamoto","year":"2008","journal-title":"J. Med. Chem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3727\/096504014X14146137738628","article-title":"Inhibition of canonical NF-\u03baB nuclear localization by (\u2212)-DHMEQ via impairment of DNA binding","volume":"22","author":"Horie","year":"2015","journal-title":"Oncol. Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"5380","DOI":"10.1016\/j.bmcl.2009.07.123","article-title":"Unusual intramolecular N\u2192O acyl group migration occurring during conjugation of (\u2212)-DHMEQ with cysteine","volume":"19","author":"Kozawa","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"529","DOI":"10.3727\/096504010X12767359113721","article-title":"Efficient cellular uptake of the novel NF-\u03baB inhibitor (\u2212)-DHMEQ and irreversible inhibition of NF-\u03baB in neoplastic cells","volume":"18","author":"Shimada","year":"2010","journal-title":"Oncol. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1039\/c2ob07104e","article-title":"Involvement of DNA binding domain in the cellular stability and importin affinity of NF-\u03baB component RelB","volume":"10","author":"Takeiri","year":"2012","journal-title":"Org. Biomol. Chem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jaci.2010.05.020","article-title":"Topical application of DHMEQ improves allergic inflammation via NF-\u03baB inhibition","volume":"126","author":"Hamasaka","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000371419","article-title":"Inhibition of MMP-2-mediated mast cell invasion by NF-\u03baB inhibitor DHMEQ in mast cells","volume":"166","author":"Noma","year":"2015","journal-title":"Int. Achieves Allergy Immunol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/08923973.2017.1312436","article-title":"External application of NF-\u03baB inhibitor DHMEQ suppresses development of atopic dermatitis-like lesions induced with DNCB\/OX in BALB\/c mice","volume":"39","author":"Jiang","year":"2017","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1095\/biolreprod.110.087577","article-title":"Apoptosis in mouse amniotic epithelium is induced by activated macrophages through the TNF receptor type 1\/TNF pathway","volume":"84","author":"Kobayashi","year":"2011","journal-title":"Biol. Reprod."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.imbio.2015.05.011","article-title":"A nuclear factor-\u03baB inhibitor, dehydroxymethylepoxyquinomicin, ameliorates GVHD in allogeneic bone marrow transplantation","volume":"220","author":"Yamanouchi","year":"2015","journal-title":"Immunobiology"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.3892\/mmr.2016.5444","article-title":"Effects of AP-1 and NF-kappa B inhibitors on colonic endocrine cells in rats with TNBS-induced colitis","volume":"14","author":"Umezawa","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.3892\/ijmm.2016.2560","article-title":"Anti-inflammatory effects of novel AP-1 and NF-\u03baB inhibitors in dextran-sulfate-sodium-induced colitis in rats","volume":"37","author":"Umezawa","year":"2016","journal-title":"Int. J. Mol. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1038\/bjc.2014.251","article-title":"Immunosuppression through constitutively activated NF-\u03baB signaling in human ovarian cancer and its reversal by a NF-\u03baB inhibitor","volume":"110","author":"Nishio","year":"2014","journal-title":"Br. J. Cancer"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Seubwai, W., Kraiklang, R., Vaeteewoottacharn, K., Umezawa, K., Okada, S., and Wongkham, S. (2014). Aberrant expression of NF-\u03baB in liver fluke associated cholangiocarcinoma: Implications for targeted therapy. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0106056"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Ito, Y., Kikuchi, E., Tanaka, N., Kosaki, T., Suzuki, E., Mizuno, R., Shinojima, T., Miyajima, A., Umezawa, K., and Oya, M. (2015). Down-regulation of NF kappa B activation is an effective therapeutic modality in acquired platinum-resistant bladder cancer. BMC Cancer, 15.","DOI":"10.1186\/s12885-015-1315-9"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.micinf.2008.04.002","article-title":"Induction of apoptosis in Epstein-Barr virus-infected B-lymphocytes by the NF-\u03baB inhibitor DHMEQ","volume":"10","author":"Miyake","year":"2008","journal-title":"Microbes Infect."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1182\/blood-2004-09-3646","article-title":"Dual targeting of transformed and untransformed HTLV-1-infected T-cells by DHMEQ, a potent and selective inhibitor of NF-\u03baB, as a strategy for chemoprevention and therapy of adult T cell leukemia","volume":"106","author":"Watanabe","year":"2005","journal-title":"Blood"},{"key":"ref_31","first-page":"2539","article-title":"Inhibition of experimental blood-borne lung metastasis by protease inhibitors","volume":"40","author":"Saito","year":"1980","journal-title":"Cancer Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s10585-012-9544-7","article-title":"Combined effect of dehydroxymethylepoxyquinomicin and gemcitabine in a mouse model of liver metastasis of pancreatic cancer","volume":"30","author":"Suzuki","year":"2013","journal-title":"Clin. Exp. Metastasis"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3727\/096504014X14024160459249","article-title":"Anoikis induction and inhibition of peritoneal metastasis of pancreatic cancer cells by a nuclear factor-kappa B inhibitor, (\u2212)-DHMEQ","volume":"21","author":"Sato","year":"2014","journal-title":"Oncol. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.bbrc.2017.02.022","article-title":"Inhibition of MMP-2-mediated cellular invasion by NF-\u03baB inhibitor DHMEQ in 3D culture of breast carcinoma MDA-MB-231 cells: A model for early phase of metastasis","volume":"485","author":"Ukaji","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1186\/ar1834","article-title":"Effect of a small molecule inhibitor of nuclear factor-\u03baB nuclear translocation in a murine model of arthritis and cultured human synovial cells","volume":"7","author":"Wakamatsu","year":"2003","journal-title":"Arthritis Res. Ther."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1093\/carcin\/bgi095","article-title":"In vivo antitumor activity of the NF-\u03baB inhibitor dehydroxymethyl-epoxyquinomicin in a mouse model of adult T-cell leukemia","volume":"26","author":"Ohsugi","year":"2005","journal-title":"Carcinogenesis"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.biopha.2011.02.003","article-title":"Possible role of peritoneal NF-\u03baB in peripheral inflammation and cancer: Lessons from the inhibitor DHMEQ","volume":"65","author":"Umezawa","year":"2011","journal-title":"Biomed. Pharmacother."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1615\/ForumImmunDisTher.2013008314","article-title":"Peritoneal NF-\u03baB as a Possible molecular target for suppression of various cancers and inflammation","volume":"4","author":"Umezawa","year":"2013","journal-title":"Forum Immunopathol. Dis. Ther."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jchromb.2008.06.027","article-title":"A simple and reliable method for determining plasma concentration of dehydroxymethylepoxyquinomicin by high performance liquid chromatography with mass spectrometry","volume":"871","author":"Watanabe","year":"2008","journal-title":"J. Chromatogr. B"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"5383","DOI":"10.1016\/j.bmcl.2009.07.120","article-title":"Efficient synthesis of (\u00b1)-parasitenone, a novel inhibitor of NF-\u03baB","volume":"19","author":"Saitoh","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nm1519","article-title":"NF-\u03baB in breast cancer cells promotes osteolytic bone metastasis by inducing osteoclastogenesis via GM-CSF","volume":"13","author":"Park","year":"2007","journal-title":"Nat. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1158\/0008-5472.CAN-06-2295","article-title":"Colon cancer cell\u2013derived tumor necrosis factor-\u03b1 mediates the tumor growth\u2013promoting response in macrophages by up-regulating the colony-stimulating factor-1 pathway","volume":"67","author":"Zins","year":"2007","journal-title":"Cancer Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jbior.2014.06.001","article-title":"Novel approaches to target NF-\u03baB and other signaling pathways in cancer stem cells","volume":"56","author":"Ukaji","year":"2014","journal-title":"Adv. Biol. Regul."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"4342","DOI":"10.1167\/iovs.06-1473","article-title":"Suppression of diabetes-induced retinal inflammation by blocking angiotensin II type 1 receptor or its downstream NF-\u03baB pathway","volume":"48","author":"Nagai","year":"2007","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/neuonc\/nor168","article-title":"Antitumor effect of dehydroxymethylepoxyquinomicin (DHMEQ), a small molecule inhibitor of nuclear factor-\u03baB, on glioblastoma","volume":"14","author":"Fukushima","year":"2012","journal-title":"Neuro-Oncology"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"5590","DOI":"10.1158\/1078-0432.CCR-04-2561","article-title":"Prevention of cancer cachexia by a novel nuclear factor \u03baB inhibitor in prostate cancer","volume":"11","author":"Kuroda","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.biopha.2008.05.003","article-title":"Inhibition of inflammatory mediator secretion by (\u2212)-DHMEQ in mouse bone marrow-derived macrophages","volume":"63","author":"Suzuki","year":"2009","journal-title":"Biomed. Pharmacother."},{"key":"ref_48","first-page":"5756","article-title":"Inhibition of NF-\u03baB with dehydroxyepoxiquinomicin modifies function of human peritoneal mesothelial cells","volume":"8","author":"Sosinnska","year":"2016","journal-title":"Am. J. Transl. Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1038\/2221286a0","article-title":"Lymphocyte to macrophage transformation in the peritoneal cavity preceding the mobilization of peritoneal macrophages to inflamed areas","volume":"222","year":"1969","journal-title":"Nature"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/19\/3\/729\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T14:57:27Z","timestamp":1760194647000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/19\/3\/729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,3]]},"references-count":49,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,3]]}},"alternative-id":["ijms19030729"],"URL":"https:\/\/doi.org\/10.3390\/ijms19030729","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,3]]}}}